MedTrace Logo

Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery

NCT01942642 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2013-09-16

No results posted yet for this study

Summary

Meibomian gland dysfunction (MGD) is a common and important disease has been investigated the pathophysiology, diagnosis, treatment modalities of MGD, however, the changes of MGD after the cataract surgery, the most popular surgery to ophthalmologist, had not been evaluated. The investigators evaluated parameters related with MGD including lid margin abnormalities, meibomian gland expressibility and meibography before and after surgery.

Conditions

  • Meibomian Gland Dysfunction

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-04-30
Completion
2013-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01942642 on ClinicalTrials.gov